世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

診断用心電計（ECG）市場：製品（安静時ECG、ストレス、モバイル心臓テレメトリ装置、植込み型ループレコーダー）およびサービス、リードタイプ（12リード、6リード、5リード）、エンドユーザー、地域別 - 2028年までの世界予測


Diagnostic Electrocardiograph (ECG) Market by Product (Resting ECG, Stress, Mobile Cardiac Telemetry Device, Implantable Loop Recorder) and Service, Lead Type (12-lead, 6-lead, 5- lead), End User, and Region - Global Forecast to 2028

世界の診断用心電図（ECG）市場は、2023年の81億米ドルから2028年には113億米ドルに達すると予測され、予測期間中のCAGRは6.9％である。心血管疾患や生活習慣病の有病率の上昇、早期心疾患診断の需要の高まり、ウ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年8月29日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		176 132 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界の診断用心電図（ECG）市場は、2023年の81億米ドルから2028年には113億米ドルに達すると予測され、予測期間中のCAGRは6.9％である。心血管疾患や生活習慣病の有病率の上昇、早期心疾患診断の需要の高まり、ウェアラブルECGデバイスの技術進歩、高齢化人口の割合の増加、医療インフラの増加、診断ECGメーカーの世界的な地理的プレゼンスの高まりなどが背景にある。

"予測期間中、安静時心電図デバイス分野が診断用心電図（ECG）市場を支配する"
製品タイプに基づき、診断用ECG市場はデバイスとソフトウェア＆サービスに区分される。デバイスセグメントは、安静時ECGデバイス、ストレスECGデバイス、ホルターモニター、イベントモニター、植え込み型ループレコーダー、モバイル心臓テレメトリーデバイス、スマートECGデバイスに分類される。安静時ECG機器セグメントは、2022年の診断ECG市場で最大シェアを占めた。コスト効率の高い安静時ECG機器の利用可能性が高まっていること、病院環境での安静時ECG機器の採用が広がっていることが要因である。

"リードタイプ別では、12リードが2022年の世界の診断用心電図（ECG）市場で最大の市場シェアを占めた"
リードタイプに基づき、診断用心電図（ECG）市場はパッチタイプの12リード、5リード、3リード、6リード、シングルリード、その他のリードタイプ（13リード、18リードなど）に区分される。2022年には、12誘導タイプが診断用ECG市場で最大のシェアを占めた。12誘導ECG装置は非常に詳細な見通しを提供し、心臓電気活動の解釈を容易にする。

"2022年、世界の心電図ECG市場は病院、診療所、心臓センターが支配する"
エンドユーザーに基づき、診断用心電図（ECG）市場は病院、診療所、心臓センター、外来手術センター、その他のエンドユーザーに区分される。病院、診療所、心臓センター部門は、2022年の世界市場で最大のシェアを占めた。その理由は、心血管疾患の有病率の増加、心臓センターの設立、病院が提供するサービスの拡大と改善のための政府資金の増加である。



"地域別ではAPAC市場が予測期間に最も高い成長率を記録する"
地域別では、診断用心電図（ECG）市場は北米、欧州、アジア太平洋、その他の地域に区分される。北米が最大のシェアを占め、診断用心電図市場を支配すると予想されている。アジア太平洋市場は、可処分所得の増加と心血管患者の増加により、大きな成長が見込まれる。病院における高度診断ECGの普及と医療費の増加

本レポートで参照した主要参入企業の内訳は以下の通り：
- 企業タイプ別ティア1～48％、ティア2～36％、ティア3～16
- 役職別Cレベル-10%、ディレクターレベル-14%、その他-76
- 地域別北米-40%、欧州-32%、アジア太平洋地域-20%、中南米-5%、MEA-3

診断用心電図（ECG）市場の主要企業は、GE HealthCare（米国）、Koninklijke Philips N.V.（オランダ）、日本光電工業株式会社（日本）、OSI Systems, Inc.（米国）、Hill-Rom Holdings, Inc. Baxter International Inc.（米国）、Mindray Medical International Limited（中国）、SCHILLER AG（スイス）、Bittium Corporation（フィンランド）、フクダ電子株式会社（日本）、BPL Medical Technologies, Inc.(日本）、BPL Medical Technologies Pvt.(インド）などがある。

調査範囲
この調査レポートは、診断用心電図（ECG）市場を製品タイプ、リードタイプ、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、個々の成長動向に関してミクロ市場を分析し、4つの主要地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握することができ、ひいては、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入する企業は、以下の戦略の1つまたは組み合わせを使用して、市場での存在感を強化することができます。

本レポートは、以下のポイントに関する洞察を提供する：
- 診断用心電図（ECG）市場の成長に影響を与える主な促進要因（心血管疾患の有病率の上昇、老年人口の増加による遠隔モニタリング需要の増加、ワイヤレスECGデバイスの技術進歩）、阻害要因（規制当局の承認が厳しく診断用ECGデバイスの承認が遅れている）、機会（発展途上国における医療支出の増加、新興市場が提供する高成長）、課題（熟練した専門家の不足）の分析
- 市場への浸透：診断用心電図（ECG）市場のトップ企業が提供する製品ポートフォリオに関する包括的情報
- 製品開発/イノベーション：診断用心電図（ECG）市場における今後の動向、研究開発活動、製品発売に関する詳細な洞察
- 市場開発：有利な新興地域に関する包括的情報
- 市場の多様化：診断用心電図（ECG）市場における新製品、成長地域、最新動向に関する網羅的情報
- 競争力評価：市場セグメント、成長戦略、収益分析、主要市場プレイヤーの製品に関する詳細な評価

ページTOPに戻る


目次

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS & EXCLUSIONS 23
1.3 STUDY SCOPE 24
FIGURE 1 MARKETS COVERED 24
1.3.1 GEOGRAPHIC SCOPE 24
1.3.2 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 25
1.5 KEY MARKET STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 26
1.7 RECESSION IMPACT ON DIAGNOSTIC ECG MARKET 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.2 PRIMARY RESEARCH 29
2.1.2.1 Key data from primary sources 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 30
FIGURE 4 DIAGNOSTIC ECG MARKET: BREAKDOWN OF PRIMARIES 30
2.2 MARKET SIZE ESTIMATION METHODOLOGY 30
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 PRODUCT-BASED MARKET ESTIMATION 31
2.2.2 END USER-BASED MARKET ESTIMATION 32
FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC ECG MARKET 32
2.2.3 PRIMARY RESEARCH VALIDATION 33
2.3 DATA TRIANGULATION 34
FIGURE 7 DATA TRIANGULATION METHODOLOGY 34
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 RESEARCH ASSUMPTIONS 35
2.4.2 RESEARCH LIMITATIONS 35
2.5 RECESSION IMPACT 35
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 36
 
3 EXECUTIVE SUMMARY 37
FIGURE 8 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 37
FIGURE 9 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET 39
4 PREMIUM INSIGHTS 40
4.1 DIAGNOSTIC ECG MARKET OVERVIEW 40
FIGURE 12 INCREASING PREVALENCE OF CVD GLOBALLY TO DRIVE MARKET GROWTH 40
4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY PRODUCT & COUNTRY (2022) 41
FIGURE 13 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2022 41
4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY TYPE, 2023 VS. 2028 41
FIGURE 14 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2022 41
4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 15 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 42
4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 16 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2028 43
4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 44
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2023 TO 2028 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
FIGURE 18 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
5.2.1 DRIVERS 46
5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases 46
5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions 46
5.2.1.3 Development of wireless monitoring and wearable cardiac devices 47
5.2.1.4 Increasing investments, funds, and grants for research on cardiac diagnosis 47
5.2.2 RESTRAINTS 48
5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets to offer high-growth opportunities 48
5.2.4 CHALLENGES 49
5.2.4.1 Dearth of skilled professionals 49
5.3 PRICING ANALYSIS 49
TABLE 2 AVERAGE SELLING PRICE OF DIAGNOSTIC ECG MONITORING PRODUCTS (2022) 49
5.4 PATENT ANALYSIS 50
FIGURE 19 PATENT ANALYSIS FOR DIAGNOSTIC ECG MARKET 50
5.5 VALUE CHAIN ANALYSIS 51
FIGURE 20 VALUE CHAIN ANALYSIS OF DIAGNOSTIC ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 51
5.6 SUPPLY CHAIN ANALYSIS 52
FIGURE 21 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS 52
5.7 ECOSYSTEM ANALYSIS 53
FIGURE 22 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS 53
5.8 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 3 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.8.1 THREAT OF NEW ENTRANTS 54
5.8.2 THREAT OF SUBSTITUTES 54
5.8.3 BARGAINING POWER OF BUYERS 54
5.8.4 BARGAINING POWER OF SUPPLIERS 54
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.9 REIMBURSEMENT SCENARIO 54
TABLE 4 CPT CODES FOR ECG PROCEDURES 55
5.10 REGULATORY ANALYSIS 55
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
5.10.1 NORTH AMERICA 57
5.10.1.1 US 57
5.10.1.2 Canada 57
5.10.2 EUROPE 58
5.10.3 ASIA PACIFIC 58
5.10.3.1 China 58
5.10.3.2 Japan 58
5.10.3.3 India 58
5.10.4 LATIN AMERICA 59
5.10.4.1 Brazil 59
5.10.4.2 Mexico 59
5.10.5 MIDDLE EAST 59
5.10.6 AFRICA 60
5.11 TRADE ANALYSIS 60
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS 60
TABLE 10 IMPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 60
TABLE 11 EXPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 61
5.12 TECHNOLOGY ANALYSIS 61
5.13 KEY CONFERENCES & EVENTS, 2023–2024 62
TABLE 12 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS 62
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR DIAGNOSTIC ECG MONITOR MANUFACTURERS 63
FIGURE 23 REVENUE SHIFT IN DIAGNOSTIC ECG MARKET 63
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 63
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 63
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 63
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 64
5.15.2 BUYING CRITERIA 64
FIGURE 25 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
TABLE 14 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
6 DIAGNOSTIC ECG MARKET, BY PRODUCT 65
6.1 INTRODUCTION 66
TABLE 15 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 66
6.2 DEVICES 66
TABLE 16 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 67
6.2.1 RESTING ECG DEVICES 67
6.2.1.1 Wide availability of resting ECG devices to support market growth 67
TABLE 17 RESTING ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 68
6.2.2 STRESS ECG DEVICES 68
6.2.2.1 High cost of stress ECG devices to limit adoption 68
TABLE 18 STRESS ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 69
6.2.3 HOLTER MONITORS 69
6.2.3.1 Growing demand for continuous monitoring to fuel growth 69
TABLE 19 HOLTER MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.4 EVENT MONITORS 70
6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth 70
TABLE 20 EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.5 IMPLANTABLE LOOP RECORDERS 71
6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth 71
TABLE 21 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 71
6.2.6 MOBILE CARDIAC TELEMETRY DEVICES 71
6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market 71
TABLE 22 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 72
6.2.7 SMART ECG MONITORS 72
6.2.7.1 Rising need to reduce treatment costs to drive adoption of smart/wearable ECG monitors 72
TABLE 23 SMART ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 73
6.3 SOFTWARE & SERVICES 73
6.3.1 SHIFT TOWARDS AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH 73
TABLE 24 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 74
7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE 75
7.1 INTRODUCTION 76
TABLE 25 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028(USD MILLION) 76
7.2 12-LEAD ECG DEVICES 76
7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH 76
TABLE 26 12-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.3 5-LEAD ECG DEVICES 77
7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION 77
TABLE 27 5-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.4 3-LEAD ECG DEVICES 78
7.4.1 ABILITY TO MEET NEEDS OF MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO SUPPORT MARKET 78
TABLE 28 3-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 78
7.5 6-LEAD ECG DEVICES 78
7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH 78
TABLE 29 6-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.6 SINGLE-LEAD ECG DEVICES 79
7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES 79
TABLE 30 SINGLE-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.7 OTHER ECG LEAD DEVICES 80
TABLE 31 OTHER ECG LEAD DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 80
 
8 DIAGNOSTIC ECG MARKET, BY END USER 81
8.1 INTRODUCTION 82
TABLE 32 DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 82
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 82
8.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS & CARDIAC CENTERS TO ACCELERATE MARKET GROWTH 82
TABLE 33 DIAGNOSTIC ECG MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION) 83
8.3 AMBULATORY SURGERY CENTERS 83
8.3.1 GROWING ADOPTION OF OUTPATIENT SURGERIES TO SUPPORT GROWTH 83
TABLE 34 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION) 84
8.4 OTHER END USERS 84
TABLE 35 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 85
9 DIAGNOSTIC ECG MARKET, BY REGION 86
9.1 INTRODUCTION 87
TABLE 36 DIAGNOSTIC ECG MARKET, BY REGION, 2021–2028 (USD MILLION) 87
9.2 NORTH AMERICA 88
FIGURE 26 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT 88
TABLE 37 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 38 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 90
TABLE 40 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 90
9.2.1 NORTH AMERICA: RECESSION IMPACT 90
9.2.2 US 91
9.2.2.1 Growing number of FDA approvals for ECG devices to support market growth 91
TABLE 41 US: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
9.2.3 CANADA 91
9.2.3.1 Growing focus of government and private organizations on providing funding for research to drive market growth 91
TABLE 42 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
9.3 EUROPE 92
TABLE 43 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 44 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 45 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 94
TABLE 46 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 94
9.3.1 EUROPE: RECESSION IMPACT 94
9.3.2 GERMANY 95
9.3.2.1 Germany to dominate diagnostic ECG market in Europe during forecast period 95
TABLE 47 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 95
9.3.3 FRANCE 95
9.3.3.1 Rising prevalence of heart failure to drive adoption of diagnostic ECG devices 95
TABLE 48 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
9.3.4 UK 96
9.3.4.1 Rising demand for home-based smart ECG devices to support market growth. 96
TABLE 49 UK: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
9.3.5 ITALY 97
9.3.5.1 Rising incidence of heart diseases to increase use of diagnostic ECG devices 97
TABLE 50 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
9.3.6 SPAIN 98
9.3.6.1 Rising geriatric population to support market growth in Spain 98
TABLE 51 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
9.3.7 REST OF EUROPE 99
TABLE 52 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
9.4 ASIA PACIFIC 100
FIGURE 27 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT 101
TABLE 53 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 55 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 103
TABLE 56 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 103
9.4.1 ASIA PACIFIC: RECESSION IMPACT 103
9.4.2 JAPAN 104
9.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 104
TABLE 57 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
9.4.3 CHINA 105
9.4.3.1 Government support for infrastructural improvement to drive market growth 105
TABLE 58 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
9.4.4 INDIA 106
9.4.4.1 Government initiatives to propel market growth 106
TABLE 59 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
9.4.5 AUSTRALIA 107
9.4.5.1 Growing adoption of telemedicine and remote patient monitoring to boost market 107
TABLE 60 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
9.4.6 SOUTH KOREA 108
9.4.6.1 Rising geriatric population to propel market growth 108
TABLE 61 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
9.4.7 REST OF ASIA PACIFIC 109
TABLE 62 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
9.5 LATIN AMERICA 109
TABLE 63 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 64 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 65 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 111
TABLE 66 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 111
9.5.1 LATIN AMERICA: RECESSION IMPACT 111
9.5.2 BRAZIL 112
9.5.2.1 Improving access to diagnostic services to drive growth 112
TABLE 67 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
9.5.3 MEXICO 113
9.5.3.1 Government support for infrastructural improvement to drive market growth 113
TABLE 68 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
9.5.4 REST OF LATIN AMERICA 113
TABLE 69 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
9.6 MIDDLE EAST & AFRICA 114
9.6.1 GROWING MEDICAL COVERAGE IN REGION TO SUPPORT GROWTH 114
TABLE 70 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 71 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 115
TABLE 72 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 116
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 117
FIGURE 28 KEY DEVELOPMENTS IN DIAGNOSTIC ECG MARKET (2020–2023) 117
10.3 REVENUE SHARE ANALYSIS 118
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022) 118
10.4 MARKET SHARE ANALYSIS 119
FIGURE 30 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 119
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 119
10.5.1 STARS 119
10.5.2 PERVASIVE PLAYERS 119
10.5.3 EMERGING LEADERS 119
10.5.4 PARTICIPANTS 120
FIGURE 31 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 120
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 121
10.6.1 PROGRESSIVE COMPANIES 121
10.6.2 DYNAMIC COMPANIES 121
10.6.3 RESPONSIVE COMPANIES 121
10.6.4 STARTING BLOCKS 121
FIGURE 32 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 122
10.7 COMPETITIVE BENCHMARKING 123
10.7.1 OVERALL COMPANY FOOTPRINT 123
TABLE 73 OVERALL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.2 COMPANY PRODUCT FOOTPRINT 123
TABLE 74 PRODUCT FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.3 COMPANY REGIONAL FOOTPRINT 124
TABLE 75 REGIONAL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 124
10.8 COMPETITIVE SCENARIO (2020–2023) 125
10.8.1 PRODUCT LAUNCHES & APPROVALS 125
TABLE 76 DIAGNOSTIC ECG MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–AUGUST 2023) 125
10.8.2 DEALS 126
TABLE 77 DIAGNOSTIC ECG MARKET: KEY DEALS (JANUARY 2020–AUGUST 2023) 126
10.8.3 OTHER DEVELOPMENTS 127
TABLE 78 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 127
11 COMPANY PROFILES 128
11.1 KEY PLAYERS 128
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 GE HEALTHCARE 128
TABLE 79 GE HEALTHCARE: COMPANY OVERVIEW 128
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 129
11.1.2 KONINKLIJKE PHILIPS N.V. 132
TABLE 80 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 132
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 133
11.1.3 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.) 136
TABLE 81 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW 136
FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 137
11.1.4 FUKUDA DENSHI 140
TABLE 82 FUKUDA DENSHI: BUSINESS OVERVIEW 140
FIGURE 36 FUKUDA DENSHI: COMPANY SNAPSHOT (2022) 141
11.1.5 MINDRAY MEDICAL INTERNATIONAL LIMITED 143
TABLE 83 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 143
FIGURE 37 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021) 144
11.1.6 NIHON KOHDEN CORPORATION 146
TABLE 84 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 146
FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 147
11.1.7 OSI SYSTEMS, INC. 149
TABLE 85 OSI SYSTEMS, INC: BUSINESS OVERVIEW 149
FIGURE 39 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 150
11.1.8 BPL MEDICAL TECHNOLOGIES 153
TABLE 86 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 153
11.1.9 SCHILLER AG 155
TABLE 87 SCHILLER AG: BUSINESS OVERVIEW 155
11.1.10 BITTIUM 157
TABLE 88 BITTIUM: BUSINESS OVERVIEW 157
FIGURE 40 BITTIUM: COMPANY SNAPSHOT (2022) 158
11.1.11 ACS DIAGNOSTICS 160
TABLE 89 ACS DIAGNOSTICS: BUSINESS OVERVIEW 160
11.1.12 ALLENGERS MEDICAL SYSTEMS LTD. 161
TABLE 90 ALLENGERS MEDICAL SYSTEMS LTD: BUSINESS OVERVIEW 161
11.1.13 BIONET 162
TABLE 91 BIONET: BUSINESS OVERVIEW 162
11.1.14 CARDIAC INSIGHT, INC. 163
TABLE 92 CARDIAC INSIGHT, INC.: BUSINESS OVERVIEW 163
11.1.15 BTL 164
TABLE 93 BTL: BUSINESS OVERVIEW 164
11.2 OTHER PLAYERS 165
11.2.1 MEDITECH EQUIPMENT CO. LTD. 165
11.2.2 MIDMARK CORPORATION 165
11.2.3 ALIVECOR, INC. 166
11.2.4 VITALCONNECT 166
11.2.5 IRHYTHM TECHNOLOGIES, INC. 167
11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD. 167
11.2.7 NASIFF ASSOCIATES, INC. 168
11.2.8 VECTRACOR 168
11.2.9 BIOMEDICAL INSTRUMENTS CO. LTD. 169
11.2.10 LIFESIGNALS, INC. 170
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 171
12.1 DISCUSSION GUIDE 171
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 174
12.3 CUSTOMIZATION OPTIONS 176
12.4 RELATED REPORTS 176
12.5 AUTHOR DETAILS 177

　

ページTOPに戻る


　

Summary

The global diagnostic electrocardiogram (ECG) market is projected to reach USD 11.3 billion by 2028 from USD 8.1 billion in 2023, at a CAGR of 6.9% during the forecast period. The rising prevalence of cardiovascular and lifestyle diseases, growing demand for early cardiac diseases diagnosis , technological advancements in wearable ECG devices, increasing proportion of aging population, increasing healthcare infrastructure and growing geographical presence of diagnostic ECG manufacturers globally.

“Resting ECG Devices segment to dominate diagnostic electrocardiogram (ECG) market during the forecast period.”
Based on product type, the diagnostic ECG market is segmented into devices and software & Services . The devices segment is categorized into resting ECG devices, stress ECG devices, Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry devices, and smart ECG devices. The resting ECG devices segment captured the largest share of diagnostic ECG market in 2022 attributed to the increasing availability of cost effective resting ECG devices and wider adoption of resting ECG devices in hospital settings.

“12 lead , by lead type , accounted for the largest market share of global diagnostic electrocardiogram (ECG) market in 2022.”
Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG market. This is mainly attributed to higher clarity obtained by using a larger number of leads; 12-lead ECG devices provide a highly detailed outlook, making it easier to interpret cardiac electrical activity.

“The hospitals, clinics, and cardiac centers to dominate the global electrocardiogram ECG market in 2022.”
Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the increasing prevalence of cardiovascular diseases, establishment of cardiac centers, and increasing government funding to expand and improve the services offered by hospitals.



“The APAC market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the diagnostic electrocardiogram (ECG) market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest share and expects to dominate the diagnostic ECG market. The Asia-Pacific market is likely witnessing significant growth owing to increase in disposable income and increase in cardiovascular patient pool. Rising penetration of advanced diagnostic ECG in hospitals, and growing healthcare expenditure

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%

The prominent players in the diagnostic electrocardiogram (ECG) market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium Corporation (Finland), Fukuda Denshi Co., Ltd. (Japan), BPL Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage
This report studies the diagnostic electrocardiogram (ECG) market based on product type, lead type, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:
• Analysis of key drivers ( rising prevalence of cardiovascular diseases, increasing geriatric population growing demand for remote monitoring, technological advancements in wireless ECG devices ) restraints (stringent regulatory approvals delaying the approval of diagnosis ECG devices ), opportunities (rising healthcare expenditure across developing countries, high growth offered by emerging markets), and challenges (lack of skilled professional) influencing the growth of diagnostic electrocardiogram (ECG) market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic electrocardiogram (ECG) market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic electrocardiogram (ECG) market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic electrocardiogram (ECG) market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS & EXCLUSIONS 23
1.3 STUDY SCOPE 24
FIGURE 1 MARKETS COVERED 24
1.3.1 GEOGRAPHIC SCOPE 24
1.3.2 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 25
1.5 KEY MARKET STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 26
1.7 RECESSION IMPACT ON DIAGNOSTIC ECG MARKET 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.2 PRIMARY RESEARCH 29
2.1.2.1 Key data from primary sources 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 30
FIGURE 4 DIAGNOSTIC ECG MARKET: BREAKDOWN OF PRIMARIES 30
2.2 MARKET SIZE ESTIMATION METHODOLOGY 30
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 PRODUCT-BASED MARKET ESTIMATION 31
2.2.2 END USER-BASED MARKET ESTIMATION 32
FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC ECG MARKET 32
2.2.3 PRIMARY RESEARCH VALIDATION 33
2.3 DATA TRIANGULATION 34
FIGURE 7 DATA TRIANGULATION METHODOLOGY 34
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 RESEARCH ASSUMPTIONS 35
2.4.2 RESEARCH LIMITATIONS 35
2.5 RECESSION IMPACT 35
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 36
 
3 EXECUTIVE SUMMARY 37
FIGURE 8 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 37
FIGURE 9 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET 39
4 PREMIUM INSIGHTS 40
4.1 DIAGNOSTIC ECG MARKET OVERVIEW 40
FIGURE 12 INCREASING PREVALENCE OF CVD GLOBALLY TO DRIVE MARKET GROWTH 40
4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY PRODUCT & COUNTRY (2022) 41
FIGURE 13 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2022 41
4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY TYPE, 2023 VS. 2028 41
FIGURE 14 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2022 41
4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 15 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 42
4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 16 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2028 43
4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 44
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2023 TO 2028 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
FIGURE 18 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
5.2.1 DRIVERS 46
5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases 46
5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions 46
5.2.1.3 Development of wireless monitoring and wearable cardiac devices 47
5.2.1.4 Increasing investments, funds, and grants for research on cardiac diagnosis 47
5.2.2 RESTRAINTS 48
5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets to offer high-growth opportunities 48
5.2.4 CHALLENGES 49
5.2.4.1 Dearth of skilled professionals 49
5.3 PRICING ANALYSIS 49
TABLE 2 AVERAGE SELLING PRICE OF DIAGNOSTIC ECG MONITORING PRODUCTS (2022) 49
5.4 PATENT ANALYSIS 50
FIGURE 19 PATENT ANALYSIS FOR DIAGNOSTIC ECG MARKET 50
5.5 VALUE CHAIN ANALYSIS 51
FIGURE 20 VALUE CHAIN ANALYSIS OF DIAGNOSTIC ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 51
5.6 SUPPLY CHAIN ANALYSIS 52
FIGURE 21 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS 52
5.7 ECOSYSTEM ANALYSIS 53
FIGURE 22 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS 53
5.8 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 3 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.8.1 THREAT OF NEW ENTRANTS 54
5.8.2 THREAT OF SUBSTITUTES 54
5.8.3 BARGAINING POWER OF BUYERS 54
5.8.4 BARGAINING POWER OF SUPPLIERS 54
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.9 REIMBURSEMENT SCENARIO 54
TABLE 4 CPT CODES FOR ECG PROCEDURES 55
5.10 REGULATORY ANALYSIS 55
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
5.10.1 NORTH AMERICA 57
5.10.1.1 US 57
5.10.1.2 Canada 57
5.10.2 EUROPE 58
5.10.3 ASIA PACIFIC 58
5.10.3.1 China 58
5.10.3.2 Japan 58
5.10.3.3 India 58
5.10.4 LATIN AMERICA 59
5.10.4.1 Brazil 59
5.10.4.2 Mexico 59
5.10.5 MIDDLE EAST 59
5.10.6 AFRICA 60
5.11 TRADE ANALYSIS 60
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS 60
TABLE 10 IMPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 60
TABLE 11 EXPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION) 61
5.12 TECHNOLOGY ANALYSIS 61
5.13 KEY CONFERENCES & EVENTS, 2023–2024 62
TABLE 12 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS 62
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR DIAGNOSTIC ECG MONITOR MANUFACTURERS 63
FIGURE 23 REVENUE SHIFT IN DIAGNOSTIC ECG MARKET 63
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 63
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 63
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 63
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 64
5.15.2 BUYING CRITERIA 64
FIGURE 25 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
TABLE 14 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
6 DIAGNOSTIC ECG MARKET, BY PRODUCT 65
6.1 INTRODUCTION 66
TABLE 15 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 66
6.2 DEVICES 66
TABLE 16 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 67
6.2.1 RESTING ECG DEVICES 67
6.2.1.1 Wide availability of resting ECG devices to support market growth 67
TABLE 17 RESTING ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 68
6.2.2 STRESS ECG DEVICES 68
6.2.2.1 High cost of stress ECG devices to limit adoption 68
TABLE 18 STRESS ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 69
6.2.3 HOLTER MONITORS 69
6.2.3.1 Growing demand for continuous monitoring to fuel growth 69
TABLE 19 HOLTER MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.4 EVENT MONITORS 70
6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth 70
TABLE 20 EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.5 IMPLANTABLE LOOP RECORDERS 71
6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth 71
TABLE 21 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 71
6.2.6 MOBILE CARDIAC TELEMETRY DEVICES 71
6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market 71
TABLE 22 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 72
6.2.7 SMART ECG MONITORS 72
6.2.7.1 Rising need to reduce treatment costs to drive adoption of smart/wearable ECG monitors 72
TABLE 23 SMART ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 73
6.3 SOFTWARE & SERVICES 73
6.3.1 SHIFT TOWARDS AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH 73
TABLE 24 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 74
7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE 75
7.1 INTRODUCTION 76
TABLE 25 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028(USD MILLION) 76
7.2 12-LEAD ECG DEVICES 76
7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH 76
TABLE 26 12-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.3 5-LEAD ECG DEVICES 77
7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION 77
TABLE 27 5-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.4 3-LEAD ECG DEVICES 78
7.4.1 ABILITY TO MEET NEEDS OF MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO SUPPORT MARKET 78
TABLE 28 3-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 78
7.5 6-LEAD ECG DEVICES 78
7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH 78
TABLE 29 6-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.6 SINGLE-LEAD ECG DEVICES 79
7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES 79
TABLE 30 SINGLE-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.7 OTHER ECG LEAD DEVICES 80
TABLE 31 OTHER ECG LEAD DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 80
 
8 DIAGNOSTIC ECG MARKET, BY END USER 81
8.1 INTRODUCTION 82
TABLE 32 DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 82
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 82
8.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS & CARDIAC CENTERS TO ACCELERATE MARKET GROWTH 82
TABLE 33 DIAGNOSTIC ECG MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION) 83
8.3 AMBULATORY SURGERY CENTERS 83
8.3.1 GROWING ADOPTION OF OUTPATIENT SURGERIES TO SUPPORT GROWTH 83
TABLE 34 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION) 84
8.4 OTHER END USERS 84
TABLE 35 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 85
9 DIAGNOSTIC ECG MARKET, BY REGION 86
9.1 INTRODUCTION 87
TABLE 36 DIAGNOSTIC ECG MARKET, BY REGION, 2021–2028 (USD MILLION) 87
9.2 NORTH AMERICA 88
FIGURE 26 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT 88
TABLE 37 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 38 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 90
TABLE 40 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 90
9.2.1 NORTH AMERICA: RECESSION IMPACT 90
9.2.2 US 91
9.2.2.1 Growing number of FDA approvals for ECG devices to support market growth 91
TABLE 41 US: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
9.2.3 CANADA 91
9.2.3.1 Growing focus of government and private organizations on providing funding for research to drive market growth 91
TABLE 42 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
9.3 EUROPE 92
TABLE 43 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 44 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 45 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 94
TABLE 46 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 94
9.3.1 EUROPE: RECESSION IMPACT 94
9.3.2 GERMANY 95
9.3.2.1 Germany to dominate diagnostic ECG market in Europe during forecast period 95
TABLE 47 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 95
9.3.3 FRANCE 95
9.3.3.1 Rising prevalence of heart failure to drive adoption of diagnostic ECG devices 95
TABLE 48 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
9.3.4 UK 96
9.3.4.1 Rising demand for home-based smart ECG devices to support market growth. 96
TABLE 49 UK: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
9.3.5 ITALY 97
9.3.5.1 Rising incidence of heart diseases to increase use of diagnostic ECG devices 97
TABLE 50 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
9.3.6 SPAIN 98
9.3.6.1 Rising geriatric population to support market growth in Spain 98
TABLE 51 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
9.3.7 REST OF EUROPE 99
TABLE 52 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
9.4 ASIA PACIFIC 100
FIGURE 27 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT 101
TABLE 53 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 55 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 103
TABLE 56 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 103
9.4.1 ASIA PACIFIC: RECESSION IMPACT 103
9.4.2 JAPAN 104
9.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 104
TABLE 57 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
9.4.3 CHINA 105
9.4.3.1 Government support for infrastructural improvement to drive market growth 105
TABLE 58 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
9.4.4 INDIA 106
9.4.4.1 Government initiatives to propel market growth 106
TABLE 59 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
9.4.5 AUSTRALIA 107
9.4.5.1 Growing adoption of telemedicine and remote patient monitoring to boost market 107
TABLE 60 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
9.4.6 SOUTH KOREA 108
9.4.6.1 Rising geriatric population to propel market growth 108
TABLE 61 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
9.4.7 REST OF ASIA PACIFIC 109
TABLE 62 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
9.5 LATIN AMERICA 109
TABLE 63 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 64 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 65 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 111
TABLE 66 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 111
9.5.1 LATIN AMERICA: RECESSION IMPACT 111
9.5.2 BRAZIL 112
9.5.2.1 Improving access to diagnostic services to drive growth 112
TABLE 67 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
9.5.3 MEXICO 113
9.5.3.1 Government support for infrastructural improvement to drive market growth 113
TABLE 68 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
9.5.4 REST OF LATIN AMERICA 113
TABLE 69 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
9.6 MIDDLE EAST & AFRICA 114
9.6.1 GROWING MEDICAL COVERAGE IN REGION TO SUPPORT GROWTH 114
TABLE 70 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 71 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 115
TABLE 72 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 116
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 117
FIGURE 28 KEY DEVELOPMENTS IN DIAGNOSTIC ECG MARKET (2020–2023) 117
10.3 REVENUE SHARE ANALYSIS 118
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022) 118
10.4 MARKET SHARE ANALYSIS 119
FIGURE 30 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 119
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 119
10.5.1 STARS 119
10.5.2 PERVASIVE PLAYERS 119
10.5.3 EMERGING LEADERS 119
10.5.4 PARTICIPANTS 120
FIGURE 31 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 120
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 121
10.6.1 PROGRESSIVE COMPANIES 121
10.6.2 DYNAMIC COMPANIES 121
10.6.3 RESPONSIVE COMPANIES 121
10.6.4 STARTING BLOCKS 121
FIGURE 32 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 122
10.7 COMPETITIVE BENCHMARKING 123
10.7.1 OVERALL COMPANY FOOTPRINT 123
TABLE 73 OVERALL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.2 COMPANY PRODUCT FOOTPRINT 123
TABLE 74 PRODUCT FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.3 COMPANY REGIONAL FOOTPRINT 124
TABLE 75 REGIONAL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 124
10.8 COMPETITIVE SCENARIO (2020–2023) 125
10.8.1 PRODUCT LAUNCHES & APPROVALS 125
TABLE 76 DIAGNOSTIC ECG MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–AUGUST 2023) 125
10.8.2 DEALS 126
TABLE 77 DIAGNOSTIC ECG MARKET: KEY DEALS (JANUARY 2020–AUGUST 2023) 126
10.8.3 OTHER DEVELOPMENTS 127
TABLE 78 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 127
11 COMPANY PROFILES 128
11.1 KEY PLAYERS 128
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 GE HEALTHCARE 128
TABLE 79 GE HEALTHCARE: COMPANY OVERVIEW 128
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 129
11.1.2 KONINKLIJKE PHILIPS N.V. 132
TABLE 80 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 132
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 133
11.1.3 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.) 136
TABLE 81 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW 136
FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 137
11.1.4 FUKUDA DENSHI 140
TABLE 82 FUKUDA DENSHI: BUSINESS OVERVIEW 140
FIGURE 36 FUKUDA DENSHI: COMPANY SNAPSHOT (2022) 141
11.1.5 MINDRAY MEDICAL INTERNATIONAL LIMITED 143
TABLE 83 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 143
FIGURE 37 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021) 144
11.1.6 NIHON KOHDEN CORPORATION 146
TABLE 84 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 146
FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 147
11.1.7 OSI SYSTEMS, INC. 149
TABLE 85 OSI SYSTEMS, INC: BUSINESS OVERVIEW 149
FIGURE 39 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 150
11.1.8 BPL MEDICAL TECHNOLOGIES 153
TABLE 86 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 153
11.1.9 SCHILLER AG 155
TABLE 87 SCHILLER AG: BUSINESS OVERVIEW 155
11.1.10 BITTIUM 157
TABLE 88 BITTIUM: BUSINESS OVERVIEW 157
FIGURE 40 BITTIUM: COMPANY SNAPSHOT (2022) 158
11.1.11 ACS DIAGNOSTICS 160
TABLE 89 ACS DIAGNOSTICS: BUSINESS OVERVIEW 160
11.1.12 ALLENGERS MEDICAL SYSTEMS LTD. 161
TABLE 90 ALLENGERS MEDICAL SYSTEMS LTD: BUSINESS OVERVIEW 161
11.1.13 BIONET 162
TABLE 91 BIONET: BUSINESS OVERVIEW 162
11.1.14 CARDIAC INSIGHT, INC. 163
TABLE 92 CARDIAC INSIGHT, INC.: BUSINESS OVERVIEW 163
11.1.15 BTL 164
TABLE 93 BTL: BUSINESS OVERVIEW 164
11.2 OTHER PLAYERS 165
11.2.1 MEDITECH EQUIPMENT CO. LTD. 165
11.2.2 MIDMARK CORPORATION 165
11.2.3 ALIVECOR, INC. 166
11.2.4 VITALCONNECT 166
11.2.5 IRHYTHM TECHNOLOGIES, INC. 167
11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD. 167
11.2.7 NASIFF ASSOCIATES, INC. 168
11.2.8 VECTRACOR 168
11.2.9 BIOMEDICAL INSTRUMENTS CO. LTD. 169
11.2.10 LIFESIGNALS, INC. 170
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 171
12.1 DISCUSSION GUIDE 171
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 174
12.3 CUSTOMIZATION OPTIONS 176
12.4 RELATED REPORTS 176
12.5 AUTHOR DETAILS 177

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/18　10:26

155.35 円

164.28 円

199.02 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.